Engineers develop A.I. System to detect often-missed cancer tumors

August 22, 2018

Doctors may soon have help in the fight against cancer thanks to the University of Central Florida's Computer Vision Research Center.

Engineers at the center have taught a computer how to detect tiny specks of lung cancer in CT scans, which radiologists often have a difficult time identifying. The artificial intelligence system is about 95 percent accurate, compared to 65 percent when done by human eyes, the team said.

"We used the brain as a model to create our system," said Rodney LaLonde, a doctoral candidate and captain of UCF's hockey team. "You know how connections between neurons in the brain strengthen during development and learn? We used that blueprint, if you will, to help our system understand how to look for patterns in the CT scans and teach itself how to find these tiny tumors."

The approach is similar to the algorithms that facial-recognition software uses. It scans thousands of faces looking for a particular pattern to find its match.

Engineering Assistant Professor Ulas Bagci leads the group of researchers in the center that focuses on AI with potential medical applications.

The group fed more than 1,000 CT scans - provided by the National Institutes of Health through a collaboration with the Mayo Clinic - into the software they developed to help the computer learn to look for the tumors.

Graduate students working on the project had to teach the computer different things to help it learn properly. Naji Khosravan, who is pursuing his doctorate degree, created the backbone of the system of learning. His proficiency at novel machine learning and computer vision algorithms led to his summer as an intern at Netflix helping the company with various projects.

LaLonde taught the computer how to ignore other tissue, nerves and other masses it encountered in the CT scans and analyze lung tissues. Sarfaraz Hussein who earned his doctorate degree this past summer, is fine-tuning the AI's ability to identify cancerous versus benign tumors, while graduate student Harish Ravi Parkash is taking lessons learned from this project and applying them see if another AI system can be developed to help identify or predict brain disorders.

"I believe this will have a very big impact," Bagci said. "Lung cancer is the number one cancer killer in the United States and if detected in late stages, the survival rate is only 17 percent. By finding ways to help identify earlier, I think we can help increase survival rates."

The team will present its finding in September at the largest premier conference for medical imaging research - the MICCAI 2018 conference in Spain. The team's work has been published in advance of the conference. https://arxiv.org/pdf/1805.02279.pdf

The next step is to move the research project into a hospital setting; Bagci is looking for partners to make that happen. After that, the technology could be a year or two away from the marketplace, Bagci said.

"I think we all came here because we wanted to use our passion for engineering to make a difference and saving lives is a big impact," LaLonde said.

Ravi Prakash agrees. He was studying engineering and its applications to agriculture before he heard about Bagci and his work at UCF. Bagci's research is in the area of biomedical imaging and machine learning and their applications in clinical imaging. Previously, Bagci was a staff scientist and the lab manager at the NIH's Center for Infectious Disease Imaging lab, in the department of Radiology and Imaging Sciences.
-end-
UCF: Founded in 1963 with a commitment to expanding opportunity and demanding excellence, the University of Central Florida develops the talent needed to advance the prosperity and welfare of our society.

With more than 66,000 students, UCF is one of the nation's largest universities, offering more than 200 degree programs at its main campus in Orlando and more than a dozen other locations in Central Florida and online.

UCF was ranked by U.S. News & World Report as among the nation's top 25 most innovative universities along with Harvard, Stanford and Duke, and has been described by The Washington Post as "part of a vanguard that is demolishing the popular belief that exclusivity is a virtue in higher education." For more information, visit ucf.edu.

University of Central Florida

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.